 Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the needed data. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
